Digestive Diseases and Sciences

, Volume 57, Issue 10, pp 2516–2518 | Cite as

Recurrent Duodenal Stricture Secondary to Untreated Crohn’s Disease

Stanford Multidisciplinary Seminars


  1. 1.
    Peeters M, Joossens S, Vermeire S, et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease. Am J Gastroenterol. 2001;96:730–734.PubMedCrossRefGoogle Scholar
  2. 2.
    Mow WS, Vasiliauskas EA, Lin Y-C, et al. Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease. Gastroenterology. 2004;126:414–424.PubMedCrossRefGoogle Scholar
  3. 3.
    Solem CA, Loftus EV Jr, Tremaine WJ, et al. Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease. Inflamm Bowel Dis. 2005;11:707–712.PubMedCrossRefGoogle Scholar
  4. 4.
    Casella G, D’Incà R, Oliva L, et al. Prevalence of celiac disease in inflammatory bowel diseases: an IG-IBD multicentre study. Dig Liver Dis. 2010;42:175–178.PubMedCrossRefGoogle Scholar
  5. 5.
    Mottet C, Juillerat P, Pittet V, et al. Upper gastrointestinal Crohn’s disease. Digestion. 2007;76:136–140.PubMedCrossRefGoogle Scholar
  6. 6.
    Nugent FW, Roy MA. Duodenal Crohn’s disease: an analysis of 89 cases. Am J Gastroenterol. 1989;84:249–254.PubMedGoogle Scholar
  7. 7.
    Singh VV, Draganov P, Valentine J. Efficacy and safety of endoscopic balloon dilation of symptomatic upper and lower gastrointestinal Crohn’s disease strictures. J Clin Gastroenterol. 2005;39:284–290.PubMedCrossRefGoogle Scholar
  8. 8.
    Shapiro M, Greenstein AJ, Byrn J, et al. Surgical management and outcomes of patients with duodenal Crohn’s disease. J Am Coll Surg. 2008;207:36–42.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Department of SurgeryStanford University School of MedicineStanfordUSA

Personalised recommendations